TCG Crossover GP II, LLC 13D and 13G filings for EyePoint Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-07 4:27 pm Purchase |
2024-10-31 | 13G | EyePoint Pharmaceuticals, Inc. EYPT |
TCG Crossover GP II, LLC | 3,572,335 5.200% |
3,572,335 (New Position) |
Filing |